VIDEO: Quantify Research at DIA’s 2025 Real-World Evidence Conference

With access to some of the highest quality health data worldwide, Quantify Research has built a reputation for delivering regulatory-grade evidence grounded in Nordic real-world evidence (RWE). Ahead of DIA’s 2025 Real-World Evidence Conference (October 16–17, San Diego, CA, US), we caught up with Kirk Geale to hear how Quantify Research is showcasing its expertise in data quality and pharmacovigilance, and what attendees can look forward to in San Diego.

You can view the entire video or view a specific question by entering ‘Fullscreen’ or navigate via the ‘Visual Table of Contents’.

• 00:33: To begin, could you tell us a little about Quantify Research and your expertise in Nordic real-world evidence?
• 02:17: At DIA’s Real-World Evidence Conference, you’ll be speaking in the session 'Ensuring Quality and Integrity of Real-World Data: Regulatory Insights.' What can attendees expect from that discussion?
• 04:41: Beyond the conference, how is Quantify continuing to deliver regulatory-grade evidence and support better patient access? 

Kirk Geale
CEO, Board Member, Quantify Research

Kirk Geale is the CEO and Board Director of the Quantify Research group. With expertise spanning economics, RWD/E, epidemiology, and strategy, he brings a unique interdisciplinary perspective to the life science industry. Dr Geale holds a PhD from Umeå University (Sweden), an MSc in Economics from Lund University (Sweden), and a BComm in Management Economics & Finance from the Gordon S. Lang School of Business and Economics at the University of Guelph (Canada). He is also a graduate of Stanford University's Executive Program for Growing Companies (USA) and the Karolinska Institute's Interdisciplinary Graduate School in Register-Based Research (Sweden).

This Conference Sneak Peek has been developed through our media partnership with Quantify Research.